Audience -Adults & Aging-All Patients & Families-Chapters-Donors & Supporters-Healthcare Providers-Kids & Young Adults-Men-Payers-Spanish Speaking Individuals-Undiagnosed-Women & Girls Type of Bleeding Disorder -All Bleeding Disorders-Hemophilia-Inhibitors-Rare Bleeding Disorders-Von Willebrand Disease Topic -Advocacy-Awareness-Blood & Product Safety-Community-COVID-19-Diversity & Inclusion-Fitness & Nutrition-Future Therapies-Health Equity-Healthcare Insurance-HIV & Hepatitis C-Bone & Joint Health-Mental Health-Pain Management-Sexual & Reproductive Health-Research-Digital Health-Treatment & Care 18 May Implementation Science May 18, 2022 - May 18, 2022 11 May Finding Financial Support May 11, 2022 - May 11, 2022 04 May Multiyear Factor VIII Expression after Adeno‐associated Virus Gene Transfer for Hemophilia A May 4, 2022 - May 4, 2022 27 Apr AAV Antibodies Update Apr 27, 2022 - Apr 27, 2022 20 Apr Medical Marijuana 101 for the Inheritable Blood Disorder Community Apr 20, 2022 - Apr 20, 2022 13 Apr Whole 1 Exome Analysis of Adolescents with Low VWF and Heavy Menstrual Bleeding Identifies Novel Genetic Associations Apr 13, 2022 - Apr 13, 2022 06 Apr The effect of emicizumab prophylaxis on long‐term self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies Apr 6, 2022 - Apr 6, 2022 30 Mar Shared Decision-Making: An Essential Element to Patient-Centricity Mar 30, 2022 23 Mar #Hemophilia: Lessons and Opportunities for Advocacy on Twitter Mar 23, 2022 16 Mar Breakthrough Bleeding Episodes in Pediatric Severe Hemophilia a Patients with and without Inhibitors Receiving Emicizumab Prophylaxis: a Single-center Retrospective Review Mar 16, 2022 09 Mar Hepatitis C Virus in Hemophilia: Health-related Quality of Life After Successful Treatment Mar 9, 2022 23 Feb Rare Bleeding Disorders in the Plains Community Feb 23, 2022 - Feb 23, 2022 16 Feb Point of Care Coagulation Testing Using ClotChip Technology Feb 16, 2022 - Feb 16, 2022 09 Feb Advocating for Your Care in the Emergency Room Feb 9, 2022 - Feb 9, 2022 02 Feb Applications of Gene Editing in Medical Science Feb 2, 2022 - Feb 2, 2022 26 Jan NHF Fellowship and Grant Application Information Session Jan 26, 2022 - Jan 26, 2022 19 Jan Evaluation of Sexual Health in People with Hemophilia Jan 19, 2022 - Jan 19, 2022 12 Jan New Hemophilia Treatments: Implications for the Coagulation Laboratory Jan 12, 2022 - Jan 12, 2022 05 Jan Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations Jan 5, 2022 - Jan 5, 2022 15 Dec 2021 Recap and the Year Ahead Dec 15, 2021 - Dec 15, 2021 08 Dec VWF Regulation in Blood Outgrowth Endothelial Cells Dec 8, 2021 - Dec 8, 2021 01 Dec Spots, Dots, and Clots Clinic: A designated combined hematology/reproductive medicine clinic at OHSU Dec 1, 2021 - Dec 1, 2021 17 Nov Navigating Time and Space: Experiences of Aging with Hemophilia Nov 17, 2021 10 Nov The Science of Pain Nov 10, 2021 Pagination First page Previous page Current page 1 Page 2 Page 3 Page 4 Next page Last page
04 May Multiyear Factor VIII Expression after Adeno‐associated Virus Gene Transfer for Hemophilia A May 4, 2022 - May 4, 2022
20 Apr Medical Marijuana 101 for the Inheritable Blood Disorder Community Apr 20, 2022 - Apr 20, 2022
13 Apr Whole 1 Exome Analysis of Adolescents with Low VWF and Heavy Menstrual Bleeding Identifies Novel Genetic Associations Apr 13, 2022 - Apr 13, 2022
06 Apr The effect of emicizumab prophylaxis on long‐term self‐reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies Apr 6, 2022 - Apr 6, 2022
16 Mar Breakthrough Bleeding Episodes in Pediatric Severe Hemophilia a Patients with and without Inhibitors Receiving Emicizumab Prophylaxis: a Single-center Retrospective Review Mar 16, 2022
09 Mar Hepatitis C Virus in Hemophilia: Health-related Quality of Life After Successful Treatment Mar 9, 2022
12 Jan New Hemophilia Treatments: Implications for the Coagulation Laboratory Jan 12, 2022 - Jan 12, 2022
05 Jan Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations Jan 5, 2022 - Jan 5, 2022
01 Dec Spots, Dots, and Clots Clinic: A designated combined hematology/reproductive medicine clinic at OHSU Dec 1, 2021 - Dec 1, 2021
